Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Aldeyra Therapeutics Inc shares valued at $178,755 were purchased by PERCEPTIVE ADVISORS LLC on Apr 05 ’24. At $4.74 per share, PERCEPTIVE ADVISORS LLC acquired 37,712 shares. The insider’s holdings grew to 9,275,851 shares worth approximately $38.87 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, PERCEPTIVE ADVISORS LLC purchased 140,281 shares, netting a total of over 655,112 in proceeds. Following the buying of shares at $4.67 each, the insider now holds 9,238,139 shares.
Before that, PERCEPTIVE ADVISORS LLC had added 309,847 shares to its account. In a trade valued at $1,267,274, the 10% Owner bought Aldeyra Therapeutics Inc shares for $4.09 each. Upon closing the transaction, the insider’s holdings increased to 309,847 shares, worth approximately $38.12 million.
As published in a research note from Oppenheimer on April 03, 2024, Aldeyra Therapeutics Inc [ALDX] has been rated up from a Perform to an Outperform and the price target has been revised to $10. Earlier on February 08, 2021, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for ALDX stock.
Analyzing ALDX Stock Performance
During the last five days, there has been a surge of approximately 12.94%. Over the course of the year, Aldeyra Therapeutics Inc shares have jumped approximately 19.37%. Shares of the company reached a 52-week high of $4.97 on 04/05/24 and a 52-week low of $2.71 on 03/15/24. A 50-day SMA is recorded $3.70, while a 200-day SMA reached $3.40. Nevertheless, trading volume fell to 4.75 million shares from 0.55 million shares the previous day.
Support And Resistance Levels for Aldeyra Therapeutics Inc (ALDX)
According to the 24-hour chart, there is a support level at 3.42, which, if violated, would cause prices to drop to 2.64. In the upper region, resistance lies at 4.87. The next price resistance is at 5.54. RSI (Relative Strength Index) is 58.84 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.17, which suggests the price will decrease in the coming days. Percent R is at 35.58%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
